Showing results (171-180 of 187) with videos related to
Sort By:
Pageof 19
Blood|April 11, 2024
Notch1 regulates hepatic thrombopoietin productionYueyue Sun, Huan Tong, Xiang Chu, et al.Nature Communications|August 10, 2023
MTH1 protects platelet mitochondria from oxidative damage and regulates platelet function and thrombosisYangyang Ding, Xiang Gui, Xiang Chu, et al.American Journal of Hematology|April 11, 2018
Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemiaJiang Cao, Gang Wang, Hai Cheng, et al.Journal of Translational Medicine|November 17, 2018
Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptorsQi Luo, Guangyu Wei, Xiaoqing Wu, et al.Frontiers in Oncology|July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective StudyKunming Qi, Zhiling Yan, Hai Cheng, et al.Frontiers in Immunology|November 4, 2022
Prolonged hematological toxicity in patients receiving BCMA/CD19 CAR-T-cell therapy for relapsed or refractory multiple myelomaHujun Li, Lina Zhao, Zengtian Sun, et al.Journal of the American Chemical Society|February 23, 2022
Multiplexing the Quantitation of MAP Kinase Activities Using Differential SensingLingyu Zeng, Tamer S Kaoud, Diana Zamora-Olivares, et al.Cytotherapy|September 16, 2024
Comprehensive characterization of cytopenia after chimeric antigen receptor-T cell infusion in patients with relapsed or refractory multiple myelomaHai Cheng, Lingyan Shao, Dandan Wang, et al.American Journal of Hematology|July 31, 2015
MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ productionWei Sang, Cong Zhang, Dianzheng Zhang, et al.Cytotherapy|April 16, 2024
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapyHai Cheng, Yingjun Sun, Xiaoxue Zhang, et al.Pageof 19